vs

Side-by-side financial comparison of CAPITAL CITY BANK GROUP INC (CCBG) and Core Laboratories Inc. (CLB). Click either name above to swap in a different company.

Core Laboratories Inc. is the larger business by last-quarter revenue ($121.8M vs $63.5M, roughly 1.9× CAPITAL CITY BANK GROUP INC). CAPITAL CITY BANK GROUP INC runs the higher net margin — 21.6% vs 4.2%, a 17.4% gap on every dollar of revenue. On growth, CAPITAL CITY BANK GROUP INC posted the faster year-over-year revenue change (6.0% vs -1.4%). CAPITAL CITY BANK GROUP INC produced more free cash flow last quarter ($80.0M vs $517.0K). Over the past eight quarters, CAPITAL CITY BANK GROUP INC's revenue compounded faster (6.0% CAGR vs -3.4%).

Texas Capital Bank is a bank headquartered in Dallas, Texas. The bank has branches located in every major city in Texas. Its parent bank holding company is Texas Capital Bancshares. It also operates an online-only banking division, Bask Bank.

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

CCBG vs CLB — Head-to-Head

Bigger by revenue
CLB
CLB
1.9× larger
CLB
$121.8M
$63.5M
CCBG
Growing faster (revenue YoY)
CCBG
CCBG
+7.5% gap
CCBG
6.0%
-1.4%
CLB
Higher net margin
CCBG
CCBG
17.4% more per $
CCBG
21.6%
4.2%
CLB
More free cash flow
CCBG
CCBG
$79.5M more FCF
CCBG
$80.0M
$517.0K
CLB
Faster 2-yr revenue CAGR
CCBG
CCBG
Annualised
CCBG
6.0%
-3.4%
CLB

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CCBG
CCBG
CLB
CLB
Revenue
$63.5M
$121.8M
Net Profit
$13.7M
$5.1M
Gross Margin
Operating Margin
29.3%
1.5%
Net Margin
21.6%
4.2%
Revenue YoY
6.0%
-1.4%
Net Profit YoY
4.7%
EPS (diluted)
$0.80
$0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCBG
CCBG
CLB
CLB
Q1 26
$121.8M
Q4 25
$63.5M
$138.3M
Q3 25
$65.9M
$134.5M
Q2 25
$63.2M
$130.2M
Q1 25
$61.5M
$123.6M
Q4 24
$59.9M
$129.2M
Q3 24
$59.7M
$134.4M
Q2 24
$58.9M
$130.6M
Net Profit
CCBG
CCBG
CLB
CLB
Q1 26
$5.1M
Q4 25
$13.7M
$4.9M
Q3 25
$15.9M
$14.2M
Q2 25
$15.0M
$10.6M
Q1 25
$16.9M
$-154.0K
Q4 24
$13.1M
$7.4M
Q3 24
$13.1M
$11.7M
Q2 24
$14.2M
$9.0M
Gross Margin
CCBG
CCBG
CLB
CLB
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CCBG
CCBG
CLB
CLB
Q1 26
1.5%
Q4 25
29.3%
11.5%
Q3 25
32.0%
15.6%
Q2 25
31.7%
11.7%
Q1 25
35.8%
3.6%
Q4 24
29.0%
11.0%
Q3 24
26.1%
14.7%
Q2 24
29.3%
12.3%
Net Margin
CCBG
CCBG
CLB
CLB
Q1 26
4.2%
Q4 25
21.6%
3.6%
Q3 25
24.2%
10.6%
Q2 25
23.8%
8.2%
Q1 25
27.4%
-0.1%
Q4 24
21.9%
5.7%
Q3 24
22.0%
8.7%
Q2 24
24.0%
6.9%
EPS (diluted)
CCBG
CCBG
CLB
CLB
Q1 26
$0.11
Q4 25
$0.80
$0.11
Q3 25
$0.93
$0.30
Q2 25
$0.88
$0.22
Q1 25
$0.99
$0.00
Q4 24
$0.78
$0.15
Q3 24
$0.77
$0.25
Q2 24
$0.83
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCBG
CCBG
CLB
CLB
Cash + ST InvestmentsLiquidity on hand
$22.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$552.9M
$275.1M
Total Assets
$4.4B
$587.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCBG
CCBG
CLB
CLB
Q1 26
$22.8M
Q4 25
$22.7M
Q3 25
$25.6M
Q2 25
$31.2M
Q1 25
$22.1M
Q4 24
$19.2M
Q3 24
$21.5M
Q2 24
$17.7M
Total Debt
CCBG
CCBG
CLB
CLB
Q1 26
Q4 25
$110.3M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CCBG
CCBG
CLB
CLB
Q1 26
$275.1M
Q4 25
$552.9M
$266.0M
Q3 25
$540.6M
$271.3M
Q2 25
$526.4M
$261.3M
Q1 25
$512.6M
$253.4M
Q4 24
$495.3M
$246.6M
Q3 24
$476.5M
$250.7M
Q2 24
$461.0M
$240.3M
Total Assets
CCBG
CCBG
CLB
CLB
Q1 26
$587.7M
Q4 25
$4.4B
$584.0M
Q3 25
$4.3B
$591.4M
Q2 25
$4.4B
$602.1M
Q1 25
$4.5B
$591.5M
Q4 24
$4.3B
$585.1M
Q3 24
$4.2B
$600.5M
Q2 24
$4.2B
$597.8M
Debt / Equity
CCBG
CCBG
CLB
CLB
Q1 26
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCBG
CCBG
CLB
CLB
Operating Cash FlowLast quarter
$87.6M
$4.0M
Free Cash FlowOCF − Capex
$80.0M
$517.0K
FCF MarginFCF / Revenue
126.1%
0.4%
Capex IntensityCapex / Revenue
12.0%
Cash ConversionOCF / Net Profit
6.39×
0.77×
TTM Free Cash FlowTrailing 4 quarters
$150.1M
$22.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCBG
CCBG
CLB
CLB
Q1 26
$4.0M
Q4 25
$87.6M
$7.9M
Q3 25
$21.6M
$8.5M
Q2 25
$32.6M
$13.9M
Q1 25
$21.9M
$6.7M
Q4 24
$63.6M
$20.6M
Q3 24
$12.8M
$13.1M
Q2 24
$24.9M
$17.1M
Free Cash Flow
CCBG
CCBG
CLB
CLB
Q1 26
$517.0K
Q4 25
$80.0M
$5.0M
Q3 25
$19.8M
$6.5M
Q2 25
$30.8M
$10.4M
Q1 25
$19.5M
$3.9M
Q4 24
$54.9M
$17.4M
Q3 24
$10.5M
$10.4M
Q2 24
$23.0M
$14.3M
FCF Margin
CCBG
CCBG
CLB
CLB
Q1 26
0.4%
Q4 25
126.1%
3.6%
Q3 25
30.1%
4.8%
Q2 25
48.7%
8.0%
Q1 25
31.7%
3.1%
Q4 24
91.7%
13.4%
Q3 24
17.6%
7.7%
Q2 24
39.0%
10.9%
Capex Intensity
CCBG
CCBG
CLB
CLB
Q1 26
Q4 25
12.0%
2.1%
Q3 25
2.6%
1.5%
Q2 25
2.9%
2.7%
Q1 25
3.9%
2.3%
Q4 24
14.5%
2.5%
Q3 24
3.8%
2.0%
Q2 24
3.3%
2.2%
Cash Conversion
CCBG
CCBG
CLB
CLB
Q1 26
0.77×
Q4 25
6.39×
1.61×
Q3 25
1.35×
0.60×
Q2 25
2.17×
1.31×
Q1 25
1.30×
Q4 24
4.86×
2.78×
Q3 24
0.97×
1.12×
Q2 24
1.76×
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons